Tetrahedral Framework Nucleic Acids Loading Ampicillin Improve the Drug Susceptibility against Methicillin-Resistant Staphylococcus aureus

The overuse of antibiotics has led to the emergence of multidrug-resistant pathogens. There is an urgent need to develop alternative therapeutic strategies to reduce mortality and morbidity related to drug-resistant bacterial infections. Self-synthesized tetrahedral framework nucleic acids (tFNAs) a...

Full description

Saved in:
Bibliographic Details
Published inACS applied materials & interfaces Vol. 12; no. 33; pp. 36957 - 36966
Main Authors Sun, Yue, Li, Songhang, Zhang, Yuxin, Li, Qirong, Xie, Xueping, Zhao, Dan, Tian, Taoran, Shi, Sirong, Meng, Lingxian, Lin, Yunfeng
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 19.08.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The overuse of antibiotics has led to the emergence of multidrug-resistant pathogens. There is an urgent need to develop alternative therapeutic strategies to reduce mortality and morbidity related to drug-resistant bacterial infections. Self-synthesized tetrahedral framework nucleic acids (tFNAs) are used as the drug loading platform to deliver ampicillin to combat methicillin-resistant Staphylococcus aureus (MRSA) infection. The results of average dimension, zeta potential, transmission electron microscopy, and ultraviolet spectrophotometry showed that tFNAs-ampicillin combined with a sufficient encapsulation rate and good stability. tFNAs-ampicillin had a better affinity to MRSA than free ampicillin because it had a better uptake by MRSA cells. Additionally, tFNAs-ampicillin had a better antibacterial effect and lower levels of resistance development than free ampicillin. The downregulation of genes related to bacterial cell wall synthesis (murA and murZ) and upregulation of a gene related to antibiotic sensibility (PBP2) were responsible for the enhanced killing effect of tFNAs-ampicillin against MRSA.
ISSN:1944-8244
1944-8252
DOI:10.1021/acsami.0c11249